Skip to main content
CAPLYTA 21 mg/1 capsule by Intra-Cellular Therapies, Inc
CAPLYTA, 21 mg/1, capsule Drug class: Atypical Antipsychotic. Available on prescription only. Listed by Intra-Cellular Therapies, Inc.
Prescription only

CAPLYTA

lumateperone

Listed by Intra-Cellular Therapies, Inc

Strength
21 mg/1
Form
Capsule
Route
Oral
Class
Atypical Antipsychotic

What it contains

  • Lumateperone 21 mg/1

FDA record

Dosage form Capsule
Route Oral
Drug class Atypical Antipsychotic
Approval route NDA — original brand approval
NDC code 72060-121
FDA application NDA209500
RxNorm concept 2275607
Package sizes listed 2
Marketed since August 2022

Other products containing Lumateperone

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

CAPLYTA

lumateperone

Strength
10.5 mg/1
Form
Capsule
Class
Atypical Antipsychotic
Rx only

Intra-Cellular Therapies, Inc

Not stocked by us — reference only

CAPLYTA

lumateperone

Strength
42 mg/1
Form
Capsule
Class
Atypical Antipsychotic
Rx only

Intra-Cellular Therapies, Inc

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.